Furthermore, both agents induce cytotoxicity independently of p53 (Hail et al, 2006; Ashkenazi, 2008), which is important when p53 mutations are common in certain cancer types and many conventional treatments such as irradiation and DNA-damaging drugs rely on p53 to induce cell death. Here, TP53 is linked to cancer.